The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 25, 2024
Filed:
Apr. 12, 2021
Applicants:
Belite Bio, Inc, Cayman Island, KY;
The Trustees of Columbia University IN the City of New York, New York, NY (US);
Inventors:
Yu-Hsin Tom Lin, San Diego, CA (US);
Cheng-Chi Irene Wang, San Diego, CA (US);
Konstantin Petrukhin, New Windsor, NY (US);
Assignees:
Belite Bio, Inc, Grand Cayman, KY;
The Trustees of Columbia University in the City of New York, New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4545 (2006.01); A61K 9/00 (2006.01); A61K 31/4985 (2006.01); A61K 31/519 (2006.01); A61K 31/5365 (2006.01); A61K 31/5383 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4545 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 31/4985 (2013.01); A61K 31/519 (2013.01); A61K 31/5365 (2013.01); A61K 31/5383 (2013.01); A61P 3/04 (2018.01); A61P 3/10 (2018.01);
Abstract
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as obesity and the like.